Citation tools
"A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes." Saudi Medical Journal
37.8
(2016):
834-842.
Web. 24 Nov. 2024.